Review · The Cream Review
NIOD CAIS3 review: what changes when you choose the serum instead of CAIL
A buying-focused comparison of NIOD’s water-based serum and lipid balm, including sizes, peptide identities and evidence limits.
A search for NIOD copper peptides can lead to two quite different purchases: Copper Amino Isolate Serum 3 1:1, known as CAIS3, and Copper Amino Isolate Lipid 1%, known as CAIL. Similar initials make them easy to confuse, especially when a store displays both on the same page.
This review is about deciding which offer you are actually comparing. It examines the current CAIS3 record beside the balm covered in our CAIL review; it does not report personal use or a trial between them. CoreAge Rx remains the site's disclosed commercial first placement, with its separate terms in the Bounce Back review.
Start with the full product name
CAIS3 is NIOD's water-based serum. CAIL is a lipid-based balm with a different copper peptide ingredient. A photograph of a blue product or the words copper amino isolate do not make these interchangeable. Save the complete name and selected size before collecting reviews, especially when older versions or abbreviated names appear in search results.
On September 26, 2026, NIOD's US information showed CAIS3 at $62 for 15 mL and $93 for 30 mL. We confirmed the 30 mL selection through the manufacturer's variant data as well as the product record. CAIL's 15 mL offer was $93. The shared $93 figure therefore refers to different products and different quantities.
Country storefronts, currencies and promotions can change that comparison. A result in pounds or euros should not be inserted into a US price table without explanation. Nor should a larger-size price be attached to whichever bottle happens to appear first in a search thumbnail.
One percent plus one percent is not two percent copper
NIOD describes CAIS3 using one percent GHK-Cu and one percent GHK. The latter is a peptide without the copper component named in GHK-Cu. Adding the two headline figures and calling the result two percent copper peptide would erase that distinction.
The full ingredient record is useful because it identifies the materials more precisely than the product's blue color or marketing shorthand. It still does not tell us the concentration of every ingredient, the stability of a bottle after use, or the amount a particular person's skin receives. Those questions require different data.
CAIL names Copper Tripeptide-1 Palmitamide in a squalane-rich lipid formula. The ingredient and the surrounding base both differ from CAIS3. A one-percent label on each product does not create a controlled comparison. It would be misleading to say that equal-looking figures mean equal exposure, equal tolerance or equal results.
This is also why we do not rank CoreAge's advertised Copper Peptide 2% above either NIOD formula. The exact species, base and finished-product evidence must be established separately. Promotional position is not a measurement of concentration or quality.
The format changes the buying question
NIOD presents CAIS3 as water-based, oil-free and silicone-free. These are manufacturer format descriptions, not our sensory observations. We have not checked how the serum feels, whether it pills under sunscreen, or whether a particular moisturizer improves its comfort.
A lighter format may interest a reader who already has a moisturizer they like. Another reader may be specifically looking for an emollient balm. Neither preference proves that the associated copper ingredient works better. The useful question is whether the product fills a defined role without making an already comfortable routine harder to maintain.
CAIL's richer composition also does not automatically establish that it suits all dry, mature or sensitive skin. Whole-formula tolerance is individual. Our mature-skin guide treats comfort as a practical requirement rather than an age-based assignment to a particular product.
Read the study footnotes separately
NIOD's CAIS3 page reports manufacturer study summaries with groups of 31 participants at four and eight weeks and 32 participants at twelve weeks, with twice-daily use. The reported measures and durations belong to those specific summaries. They should not be combined into a larger invented trial population.
We have not independently appraised full study reports establishing a head-to-head advantage over CAIL. The existence of two sets of manufacturer results does not supply that missing comparison. Different participant groups, baselines, questionnaires and measurement methods can produce numbers that look comparable while answering different questions.
Likewise, an improvement observed within a study is not automatically the amount caused by the copper component alone. A finished formula contains other ingredients, and study design determines how much can be attributed to a particular intervention. Consumer feedback and objective measurements also deserve separate labels.
Readers who want to examine the language in more detail can use our clinical-claims guide. The practical aim is not to dismiss every brand study; it is to avoid asking a short marketing summary to establish more than it actually reports.
What the size arithmetic can tell you
At the captured US prices, CAIS3 costs approximately $4.13 per mL in the 15 mL size and $3.10 per mL in the 30 mL size. CAIL's listed 15 mL tube is $6.20 per mL. These are simple container-price calculations before tax or shipping, not cost-per-result estimates.
The larger CAIS3 bottle has a lower listed unit price, but buying more of an untried formula may be a poor fit if you do not know whether you will use it comfortably. A smaller initial outlay and a lower per-mL price are different purchasing priorities. Neither requires a clinical ranking.
Bottle longevity remains unknown without actual usage information. Do not infer that a serum and balm last equally long because their container sizes match. Our cost and value guide also explains why these retail calculations cannot be directly compared with a provider's monthly starting price.
Check directions before combining purchases
Use the instructions associated with the exact current product. Do not move a CAIL application rule onto CAIS3 simply because both are NIOD copper products. Formula-specific manufacturer guidance should also be distinguished from general internet claims that whole ingredient categories can never share a routine.
AAD advice about introducing a cosmetic through a small-area trial can help identify an obvious reaction, but it is not diagnostic patch testing. If you are using a prescription, managing an active skin condition or recovering from a procedure, ask the treating clinician how an optional product fits. This review cannot settle that from a list of ingredients.
A comparison with a different familiar ingredient can be useful when it clarifies the goal. Our copper peptides and niacinamide guide asks what each study tested rather than naming a universal winner. Keep that same discipline here: buy the product whose verified details fit the question you are trying to answer, and leave unresolved claims unresolved.
The references
Sources behind this article
Source access dates appear below. Product pages describe commercial offers and manufacturer claims, not independent product tests.
- NIOD — Copper Amino Isolate Serum 3 1:1
US 15 mL $62 and 30 mL $93; 30 mL verified in manufacturer variant response. Described 1% GHK-Cu plus 1% GHK is not 2% copper peptide. Manufacturer study summaries are not a head-to-head CAIL comparison. Checked 2026-09-26.
- NIOD — Copper Amino Isolate Lipid 1% (CAIL)
US page lists 15 mL at $93, a balm format and Copper Tripeptide-1 Palmitamide. Manufacturer study summaries are not a published head-to-head comparison. Checked 2026-09-26.
- FDA — Cosmetics labeling guide
Ingredient-order conventions have exceptions, including ingredients at 1% or less. A position in a list is not a disclosed exact concentration. Checked 2026-09-26.
- American Academy of Dermatology — Testing skin care products
A small-area home product trial is different from diagnostic patch testing. Prescription and post-procedure use need the treating clinician’s instructions. Checked 2026-09-27.